Funding · Company
ITERATIVE SCOPES, INC.
Cambridge, MABiotech & Pharma
ITERATIVE SCOPES, INC. of Cambridge, MA has disclosed $172M across 2 Form D offerings filed with the SEC between Aug 3, 2021 and Dec 14, 2021.
$172M
Total disclosed
2
Form D offerings
2017
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$140M
Form D · Dec 14, 2021 ↗
Q4 2021
· target $150M
Filing details
HeadquartersCambridge, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2017SEC CIK0001874104Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →